Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A link between hurricane-induced tree sprouting, high stem density and short canopy in tropical dry forest.

Tree physiology·2007
Same author

Influence of Size on Fate and Ecological Effects of Kepone in Physical Models.

Ecological applications : a publication of the Ecological Society of America·1991
Same journal

The Emerging Role of Copeptin.

The Clinical biochemist. Reviews·2022
Same journal

Proceedings of the Australasian Association of Clinical Biochemistry and Laboratory Medicine's 2021 Virtual Scientific Conference.

The Clinical biochemist. Reviews·2022
Same journal

Report of the Survey Conducted by RCPAQAP on Current Practices for Beta-Migrating Paraprotein Reporting.

The Clinical biochemist. Reviews·2021
Same journal

The Role of PINP in Diagnosis and Management of Metabolic Bone Disease.

The Clinical biochemist. Reviews·2021
Same journal

Proceedings of the Australasian Association of Clinical Biochemistry and Laboratory Medicine's 2020 Virtual Scientific Conference.

The Clinical biochemist. Reviews·2020
Same journal

Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

The Clinical biochemist. Reviews·2020
See all related articles

Related Experiment Video

Updated: Jun 29, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

Selection of a suitable assay.

Peter G Murphy1

  • 1Thermo Fisher Scientific, Noble Park, Victoria, Australia. office@aacb.asn.au

The Clinical Biochemist. Reviews
|October 15, 2008
PubMed
Summary
This summary is machine-generated.

This article outlines the three-stage process for introducing new diagnostic methods into clinical laboratories. It provides strategies for selecting suitable methods and a practical example for application.

More Related Videos

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Experiment Videos

Last Updated: Jun 29, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Area of Science:

  • Clinical diagnostics
  • Laboratory medicine
  • Method validation

Background:

  • Clinical diagnostic laboratories require robust methods for accurate patient care.
  • Introducing new or modified methods is a complex, multi-stage process.
  • Method selection is critical for laboratory efficiency and diagnostic accuracy.

Purpose of the Study:

  • To provide an overview of the three-stage process for introducing new/modified methods in clinical diagnostic labs.
  • To outline general principles and strategies for selecting suitable diagnostic methods.
  • To illustrate method selection principles with a practical case example.

Main Methods:

  • Literature review of method introduction and validation processes.
  • Development of a strategic framework for method selection.
  • Case study analysis of a specific diagnostic method implementation.

Main Results:

  • A structured three-stage approach (e.g., pre-analytical, analytical, post-analytical) for method implementation.
  • Key principles for method selection including analytical performance, cost-effectiveness, and clinical utility.
  • Demonstration of applying selection strategies to a real-world laboratory scenario.

Conclusions:

  • A systematic approach enhances the successful integration of new diagnostic methods.
  • Careful method selection optimizes laboratory resources and diagnostic test performance.
  • The outlined framework provides a practical guide for clinical laboratory professionals.